Similar companies
Did Organogenesis Beat Earnings?
Organogenesis (ORGO) reported Q4 '25 revenue of $225M, up 77.7% year-over-year, with reported EPS of $0.31. That topped the $0.22 analyst estimate by 43.5% — an earnings beat.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Organogenesis’s job postings, web traffic, and employee business outlook. See the full ORGO stock analysis or the earnings calendar for upcoming reports.
ORGO Earnings Surprise History (EPS vs. Estimate)
| Quarter | Estimated EPS | Reported EPS | Surprise |
|---|---|---|---|
| Q4 '25 | $0.22 | $0.31 | Beat +43.5% |
| Q3 '25 | $0.07 | $0.18 | Beat +157.1% |
| Q4 '24 | $0.02 | $0.07 | Beat +230.0% |
| Q3 '24 | $0.02 | $0.10 | Beat +400.0% |
| Q2 '24 | $0.02 | $0.04 | Beat +100.0% |
Organogenesis Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 115M | 127M | 87M | 101M | 150M | 225M | 37M | 44M |
| Gross margin | 76.7% | 75.5% | 72.6% | 72.6% | 75.9% | 77.8% | -2.5% | 45.9% |
| Operating margin | 5.4% | 8.1% | -23.3% | -10.7% | 14.4% | 29.0% | -174.7% | -116.5% |
| Net income | 12M | 7.7M | -19M | -9.4M | 22M | 44M | -56M | -99M |
| Net margin | 10.7% | 6.1% | -21.7% | -9.3% | 14.3% | 19.4% | -150.9% | -227.0% |
| EPS | $0.10 | $0.07 | — | — | $0.18 | $0.31 | — | — |
Organogenesis Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Organogenesis’s quarterly revenue moved from $115M to $44M. Net margin compressed from 10.7% to -227%, against a 45.9% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. Organogenesis has beaten Wall Street EPS estimates in 5 of its last 5 reported quarters.
When Is Organogenesis’s Next Earnings Date?
Organogenesis reports earnings on a quarterly schedule. Its most recent report covered Q4 '25. For the confirmed upcoming date — and every other company reporting soon — see the ORGO earnings calendar.
Frequently Asked Questions: Organogenesis Earnings
Organogenesis's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Organogenesis reported Q4 '25 EPS of $0.31 on revenue of $225M (+77.7% YoY). Organogenesis beat estimates, reporting $0.31 vs. the $0.22 estimate.
Organogenesis reported Q4 '25 revenue of $225M, up 77.7% from the same quarter a year earlier.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the ORGO AI Score.
